Percentage of PCs and BM involvement by tumor in WM samples and their correlation with contamination signature and clustering
Samples . | PCs in purified samples, % . | BM involvement, % . | Contamination signature . | Clustering . |
|---|---|---|---|---|
| WM8 | 25 | 20-30 | Nil | WM 1 |
| WM15 | 16 | 50-60 | Nil | WM 1 |
| WM22 | NA | 60-70 | Nil | WM 1 |
| WM25 | 8 | 80 | Nil | WM 1 |
| WM2 | 45 | 10 | Monocytes | WM 1 |
| WM10 | 26 | 80-90 | Nil | WM 1 |
| WM24 | 70 | 10-20 | Nil | WM 2 |
| WM17 | 38 | 80 | Nil | WM 2 |
| WM3 | 18 | 30 | Monocytes | WM 2 |
| WM12 | 26 | 20 | Nil | WM 2 |
| WM5 | 90 | 60-70 | Nil | WM 2 |
| WM19 | NA | NA | Nil | WM 2 |
| WM20 | NA | NA | Monocytes | WM 2 |
| WM11 | 28 | 30 | Monocytes | WM 2 |
| WM4 | 36 | 20-25 | Pre-B | WM 2 |
| WM18 | NA | NA | Pre-B | WM 2 |
| WM7 | NA | 30 | Pre-B | WM 2 |
| WM13 | 23 | 20 | Pre-B | WM 2 |
| WM16 | 14 | 20-30 | Pre-B | WM 2 |
| WM9 | 22 | 10 | Pre-B | WM 2 |
| WM23 | 95 | 30 | Monocytes | WM 3 |
| WM26 | 94 | 10 | Monocytes | WM 3 |
| WM14 | 49 | <5 | Monocytes | WM 3 |
Samples . | PCs in purified samples, % . | BM involvement, % . | Contamination signature . | Clustering . |
|---|---|---|---|---|
| WM8 | 25 | 20-30 | Nil | WM 1 |
| WM15 | 16 | 50-60 | Nil | WM 1 |
| WM22 | NA | 60-70 | Nil | WM 1 |
| WM25 | 8 | 80 | Nil | WM 1 |
| WM2 | 45 | 10 | Monocytes | WM 1 |
| WM10 | 26 | 80-90 | Nil | WM 1 |
| WM24 | 70 | 10-20 | Nil | WM 2 |
| WM17 | 38 | 80 | Nil | WM 2 |
| WM3 | 18 | 30 | Monocytes | WM 2 |
| WM12 | 26 | 20 | Nil | WM 2 |
| WM5 | 90 | 60-70 | Nil | WM 2 |
| WM19 | NA | NA | Nil | WM 2 |
| WM20 | NA | NA | Monocytes | WM 2 |
| WM11 | 28 | 30 | Monocytes | WM 2 |
| WM4 | 36 | 20-25 | Pre-B | WM 2 |
| WM18 | NA | NA | Pre-B | WM 2 |
| WM7 | NA | 30 | Pre-B | WM 2 |
| WM13 | 23 | 20 | Pre-B | WM 2 |
| WM16 | 14 | 20-30 | Pre-B | WM 2 |
| WM9 | 22 | 10 | Pre-B | WM 2 |
| WM23 | 95 | 30 | Monocytes | WM 3 |
| WM26 | 94 | 10 | Monocytes | WM 3 |
| WM14 | 49 | <5 | Monocytes | WM 3 |
NA indicates not available